[PDF] Top 20 Guardini, Romano - Dominio de Dios y Libertad Del Hombre
Has 10000 "Guardini, Romano - Dominio de Dios y Libertad Del Hombre" found on our website. Below are the top 20 most common "Guardini, Romano - Dominio de Dios y Libertad Del Hombre".
Vascular endothelial growth factor genetic polymorphisms and susceptibility to age-related macular degeneration in Tunisian population
... International Age-Related Maculopathy Epidemiologic Study ...included age, gender, personal/familial history of AMD and risk factors (tobacco use, arterial hypertension, hypercholesterolemia and car- ... See full document
43
Lasting Controversy on Ranibizumab and Bevacizumab
... Vascular endothelial growth factor (VEGF), an important angiogenic factor that is able to stimulate the proliferation and migration of endothelial cells, is the best-studied ... See full document
5
Genetic biomarkers in the VEGF pathway predicting response to anti-VEGF therapy in age-related macular degeneration
... Objective Age- related macular degeneration (ARMD) is a leading cause of visual ...anti- vascular endothelial growth factor (VEGF) are the standard treatment for ... See full document
85
Stem cells: a new paradigm for disease modeling and developing therapies for age related macular degeneration
... [39]. Genetic studies of AMD determined by candidate gene approaches and genome wide association studies demonstrate the involvement of an inflammatory com- ponent ...[40]. Polymorphisms on chromosome 1 in ... See full document
7
Recent developments in the treatment of age related macular degeneration
... survival factor for retinal neurons and that chronic inhibition of VEGF-A function in normal adult animals leads to a significant loss of retinal ganglion cells ... See full document
83
Assessing quality of life in the treatment of patients with age-related macular degeneration: clinical research findings and recommendations for clinical practice
... “age-related macular degeneration,” “wet AMD,” “neovascular AMD,” “burden of illness,” “cost,” “cost effectiveness,” “prevalence,” “blindness,” “quality of life,” “health-related ... See full document
7
Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration
... Wet Age-related Macular Degenera- tion), the DRAW study (A Pharmacokinetic Study of Intra- vitreal Aflibercept in Vitrectomized and Non-vitrectomized Eyes with Wet Age-related ... See full document
8
Effect of carotenoids dietary supplementation on macular function in diabetic patients
... Changes in retinal function can be depicted in detail by means of mfERG recording, which is essential mainly for the investigation of macular lesions. It has been shown that in all types of maculopathy there is a ... See full document
13
<p>Factors Affecting Compliance to Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in a Cohort of Jordanian Patients</p>
... cant factor affecting ...perceived susceptibility, perceived barriers, perceived bene fi ts, and unilaterality of the injection are all factors that may affect patient ... See full document
7
Association of Htra1 Gene Polymorphisms with the Risk of Developing AMD in Iranian Population
... transcriptional factor binding sites in the HTRA1 gene promoter region for adaptor related protein complex 2α (AP2α) and serum response factor (SRF) ...be related to the increased risk of ... See full document
14
The role of aflibercept in the management of diabetic macular edema
... Trap-Eye in vision impairment due to DME) were two multicenter, randomized, double-masked, active-controlled Phase III trials of 872 eyes with center-involving DME. VISTA was conducted in the US only, whereas VIVID was ... See full document
15
Nurse-administered intravitreal injections of anti-VEGF: study protocol for noninferiority randomized controlled trial of safety, cost and patient satisfaction
... has risen considerably since the treatment was first in- troduced a decade ago [4, 5]. Elderly people with AMD make up the largest group of patients receiving IVI and the prevalence of the disease increases with ... See full document
9
Evaluation of effect of bevacizumab on central subfield macular thickness in the injected and contralateral (untreated) eye of patients with bilateral diabetic macular oedema
... Subjects absent at any one of the three visits were also excluded from the study. Proper data were obtained from 31 subjects (20 men and 11 women) and were included in the analysis (table 1). The mean age (±SD) ... See full document
9
Major single nucleotide polymorphisms in polypoidal choroidal vasculopathy: a comparative analysis between Thai and other Asian populations
... A total of 97 patients with PCV and 102 normal controls were included for genetic analysis. No significant difference between these two groups was found for the demographic characteristics (Table 1). No ... See full document
6
Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration
... phism rs1061170 in the CFH (Complement Factor H) gene and response to anti-VEGF treatment. The results of 10 studies (1,510 patients), showed that polymorphism rs1061170 was a predictor of treatment response to ... See full document
21
The effect of ranibizumab and aflibercept treatment on the prevalence of outer retinal tubulation and its influence on retreatment in neovascular age-related macular degeneration
... branching networks [3]. ORTs have been observed in many retinal diseases, including exudative age-related macular degeneration (AMD) [2]. Based on histological reports, the border of the outer ... See full document
21
Preliminary in vitro and in vivo assessment of a new targeted inhibitor for choroidal neovascularization in age-related macular degeneration
... the ocular neovascularization efficiently, but require repeated intraocular injections that carry a risk of injec- tion-related adverse events, including ocular inflamma- tion, retinal injury or detachment, and ... See full document
18
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
... of age or older who were diag- nosed with neovascular AMD between February 2011 and March 2013 at Korea University Medical ...AMD. Age-matched controls were selected from the spectral domain optical ... See full document
33
Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept
... Figure 1 Left panel: carotenoids, vitamin E and cholesterol are delivered to the retinal pigment epithelium from the choriocapillaris. After initial processing within the retinal pigment epithelium, these molecules are ... See full document
19
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration: a meta-analysis of randomized controlled trials
... Efficacy was assessed by the mean change in best cor- rected visual acuity (BCVA) and in central macular thick- ness (CMT) from baseline at 1 and 2 years of follow up. Safety was assessed based on the proportions ... See full document
8
Related subjects